Avidity Partners Management LP Adicet Bio, Inc. Transaction History

Avidity Partners Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.26 - $20.81 $32 Million - $64.9 Million	-3,120,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $991,533 - $1.72 Million	85,996 Added 2.83%	3,120,000 $62.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $4.53 Million - $10.7 Million	614,404 Added 25.39%	3,034,004 $53.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $1.06 Million - $1.68 Million	169,100 Added 7.51%	2,419,600 $19 Million
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $188,395 - $326,565	20,500 Added 0.92%	2,250,500 $23.2 Million
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $27 Million - $38.3 Million	2,230,000 New	2,230,000 $29.2 Million

53.1M

27.2K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $33.2M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.